Related Experiment Video
Updated: May 9, 2026
06:18
Multiplexed Isothermal Amplification Based Diagnostic Platform to Detect Zika, Chikungunya, and Dengue 1
Published on: March 13, 2018
Complement alternative pathway genetic variation and Dengue infection in the Thai population
R Kraivong1, S Vasanawathana, W Limpitikul
1Molecular Immunology, Imperial College, London, UK.
Clinical and Experimental Immunology
|August 8, 2013
Summary
The study found no link between specific gene variants in the complement system (complotype) and Dengue hemorrhagic fever severity in Thailand. Insufficient statistical power may have limited findings for certain Dengue virus gene variants.
Area of Science:
- Immunology
- Genetics
- Infectious Diseases
Background:
- Dengue virus infection presents a spectrum of illness, from mild Dengue fever to severe Dengue hemorrhagic fever.
- The complement system, a key immune component, is activated during Dengue infection, with activation levels correlating with disease severity.
- Genetic variations in complement proteins, known as the complotype, may influence Dengue disease outcomes.
Purpose of the Study:
- To investigate the hypothesis that the complotype influences Dengue disease severity during secondary Dengue virus infections.
- To assess the association of specific complement factor B, C3, and complement factor H (CFH) polymorphisms with Dengue infection severity in a Thai population.
Main Methods:
- Genotyping of participants for specific polymorphisms in complement factor B, C3, and CFH.
- Analysis of the association between identified complotypes and Dengue infection severity.
- In vitro assessment of potential interactions between CFH and Dengue non-structural protein 1 (NS1).
Main Results:
- No significant association was detected between the examined complotype polymorphisms and Dengue infection severity in the Thai population.
- Minor allele frequencies for factor B and C3 polymorphisms were low (<10%), limiting statistical power to detect associations.
- No direct interaction was observed between CFH and Dengue NS1 in experimental models.
Conclusions:
- The complotype does not appear to influence Dengue infection severity in the studied Thai population.
- Further research with larger cohorts is needed to fully explore the role of complement genetics in Dengue pathogenesis, especially for low-frequency alleles.
More Related Videos
Related Concept Videos
02:32Exon Recombination
The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes.
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:09Mutation, Gene Flow, and Genetic Drift
In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
01:27Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...